Related Experiment Video
Updated: Jan 27, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
10.6K
Qatar Biobank Cohort Study: Study Design and First Results
Asma Al Thani1,2,3, Eleni Fthenou1, Spyridon Paparrodopoulos1
1Qatar Biobank for Medical Research, Qatar Foundation for Education, Science, and Community, Doha, Qatar.
American Journal of Epidemiology
|March 31, 2019
Summary
The Qatar Biobank (QBB) study collected health data and biological samples from over 17,000 participants. This valuable resource supports research into noncommunicable diseases like diabetes and hypertension.
Area of Science:
- Population Health
- Genomics
- Epidemiology
Background:
- Established in 2012, the Qatar Biobank (QBB) is a prospective, population-based cohort study.
- QBB aims to build a comprehensive repository of health data and biological samples for research.
- The study targets 60,000 Qataris or long-term residents aged 18+.
Purpose of the Study:
- To create an accessible resource for local and international scientists.
- To enable evidence-based research on disease development.
- To investigate associations between genetic/environmental factors and health outcomes.
Main Methods:
- Agnostic hypothesis-driven study design.
- Data collection via questionnaires, biological samples, imaging, and -omics.
- Prospective follow-up of participants every 5 years.
Main Results:
- Recruited 17,065 participants (28% of target) with over 2 million biological samples.
- Multinational cohort (33 nationalities) with a mean age of 40.5 years.
- Prevalence of key noncommunicable diseases: dyslipidemia (30.1%), diabetes (17.4%), hypertension (16.8%), and asthma (9.1%).
Conclusions:
- The Qatar Biobank provides a rich dataset for studying noncommunicable diseases.
- The repository supports global scientific research into disease etiology.
- QBB is a significant resource for understanding health in the Qatari population and beyond.
Keywords:
Middle EastQatar Biobanknoncommunicable diseasespopulation-based cohort studyresearch platformMore Related Videos
Related Concept Videos
01:15Study Design in Statistics
10.0K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
10.0K
01:20Study Designs in Epidemiology
938
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
938
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
225
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
225
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
244
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
244
01:27Bioavailability Study Design: Absolute Versus Relative Bioavailability
327
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
327
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
146
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
146